SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000912057-02-030360
Filing Date
2002-08-08
Accepted
2002-08-07 20:22:31
Documents
4

Document Format Files

Seq Description Document Type Size
1 SC 13D/A a2086192zsc13da.htm SC 13D/A 20222
3 FIRST AMENDMENT TO STOCKHOLDERS RIGHTS AGREEMENT a2086192zex-99_a.txt EX-99.A 16959
4 PRESS RELEASE DTD JULY 30, 2002 a2086192zex-99_b.txt EX-99.B 7795
5 STOCK VOTING AGREEMENT a2086192zex-99_c.txt EX-99.C 16259
  Complete submission text file 0000912057-02-030360.txt   63594
Mailing Address
Business Address 100 ABBOTT PARK ROAD D-322 AP6D ABBOTT PARK IL 60064-3500 8479376100
ABBOTT LABORATORIES (Filed by) CIK: 0000001800 (see all company filings)

IRS No.: 360698440 | State of Incorp.: IL | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 4611 UNIVERSITY DRIVE DURHAM NC 27707
Business Address 4611 UNIVERSITY DRIVE DURHAM NC 27707 9194935980
TRIANGLE PHARMACEUTICALS INC (Subject) CIK: 0001022622 (see all company filings)

IRS No.: 561930728 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-47359 | Film No.: 02722265
SIC: 2834 Pharmaceutical Preparations